According to Mager et al. [46], TGF-beta could indirectly exert a pro-tumorigenic effect on CRC cells, via the stroma, as TGF-beta may promote interleukin 11 secretion by CAFs [159], activating STAT3 and this way stimulating the proliferation of tumor cells [160]. Here, STAT3 is linked to colorectal carcinoma.